Brian Stauffer

Has grant

Division Chief, Cardiology NonInvasive

Denver Health & Hospital Authority
Country flagUnited States

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Brian Stauffer is the Division Chief of Cardiology NonInvasive at Denver Health & Hospital Authority in the United States. His research focuses on cardiovascular health, exploring topics such as heart failure representation in exercise trials, the therapeutic effects of elamipretide, and the impact of gonadal status on artery stiffness. Additionally, he investigates the role of exercise training in mitigating cardiovascular risks among diverse populations and the mechanisms underlying age-related endothelial dysfunction.

Recent Grants

Grant: Close

Cardiolipin Mechanisms Underlying Mitochondrial Dysfunction in the Heart

Open Date: 2023-07-01

Close Date: 2025-06-30

Grant: Close

Bioenergetics and Myofibril Function in Pediatric Dilated Cardiomyopathy

Open Date: 2019-07-01

Close Date: 2022-06-30

Grant: Close

Molecular and Functional Mechanisms of Pediatric Heart Failure

Open Date: 2011-12-01

Close Date: 2016-11-30

Grant: Close

Molecular and Functional Mechanisms of Pediatric Heart Failure

Open Date: 2011-12-01

Close Date: 2016-11-30

Grant: Close

Cardiac Beta-Adrenergic Adaptation in Pediatric Heart Failure

Open Date: 2009-09-01

Close Date: 2011-08-31

Articles (10)

Year:

2026

Year:

2025

Year:

2024

Year:

2024

Year:

2023

microRNAs (miRs) are small non-coding single-stranded RNAs that regulate gene expression. We previously evaluated expression of miRs in the cardiac tissue of children with dilated cardiomyopathy (DCM) using miRNA-seq. However, a comparative analysis of serum and cardiac miRs has not been performed in this population. The current study aimed to evaluate miR levels in the serum of pediatric DCM patients compared to healthy non-failing (NF) donor controls and investigate the association between miR levels in tissue and sera from the same pediatric DCM patients. Defining the relationship between serum and tissue miRs may allow the use of circulating miRs as surrogate markers of cardiac miRs. miR levels were investigated through miR-array in sera [n = 10 NF, n = 12 DCM] and miR-seq in tissue (n = 10 NF, n = 12 DCM). Pathway analysis was investigated using the miR enrichment analysis and annotation tool (miEAA) for the five miRs commonly dysregulated in the sera and tissue of pediatric DCM patients. Functional analysis of miRs commonly dysregulated in the sera and tissue of pediatric DCM patients suggests altered pathways related to cell growth, differentiation and proliferation, inflammation, mitochondrial function, and metabolism. These findings suggest that circulating miRs could reflect altered levels of cardiac tissue miRs.

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Collaborators (8)

CHRISTOPHER DESOUZA

University of Colorado Boulder

UNITED STATES
View details

Matthew Armstrong

Assistant Professor

Syracuse University

UNITED STATES
View details

Lyndsey DuBose

Assistant Professor Adjoint

University of Colorado Anschutz Medical Campus

UNITED STATES
View details

Megan M. Wenner

-

UNITED STATES
View details

Sydney Shuff

Professional Research Assistant

University of Colorado Boulder

UNITED STATES
View details

Kerrie L. Moreau

University of Colorado Anschutz Medical Campus

UNITED STATES
View details

Anastacia Garcia

Assistant Professor

University of Colorado Anschutz Medical Campus

UNITED STATES
View details

Carmen C. Sucharov

University of Colorado School of Medicine

UNITED STATES
View details
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.